InfuSystem Holdings (INFU) Other financing activities (2015 - 2026)
InfuSystem Holdings (INFU) posted Other financing activities of $6.1 million for Q1 2026, down 8.61% on a QoQ basis from $6.7 million in Q4 2025, and up 3764.78% year-over-year from $159000.0 in Q1 2025.
InfuSystem Holdings (INFU) Other financing activities (2015 - 2026) Analysis & Trends
InfuSystem Holdings' Other financing activities history runs 12 years deep, the most recent figure standing at $6.1 million for Q1 2026.
- Quarterly Other financing activities rose 3764.78% year-over-year to $6.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $54.2 million (up 6.78% YoY) and the FY2025 annual result came in at $48.2 million, down 5.06% from the prior year.
- Other financing activities was $6.1 million for Q1 2026 at InfuSystem Holdings, down from $6.7 million in the prior quarter.
- Across five years, Other financing activities topped out at $50.4 million in Q4 2024 and bottomed at -$31.4 million in Q3 2024.
- A 5-year average of $9.9 million and a median of $6.4 million in 2025 frame the typical range for Other financing activities.
- Annual changes were most pronounced in 2022 — Other financing activities slumped 184.69% — and 2023, when it surged 10285.89%.
- InfuSystem Holdings' Other financing activities stood at $205000.0 in 2022, then soared by 4175.12% to $8.8 million in 2023, then jumped by 475.27% to $50.4 million in 2024, then plunged by 86.66% to $6.7 million in 2025, then retreated by 8.61% to $6.1 million in 2026.
- Business Quant data shows INFU's Other financing activities at $6.1 million in Q1 2026, $6.7 million in Q4 2025, and $41.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | InfuSystem Holdings | 179.47 Mn | 177.37 Mn | 19.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.15 Mn |
| Mar 31, 2026 | 6.15 Mn |
| Dec 31, 2025 | 6.72 Mn |
| Dec 31, 2025 | 6.72 Mn |
| Sep 30, 2025 | 41.34 Mn |
| Sep 30, 2025 | 41.34 Mn |
| Mar 31, 2025 | 159,000.00 |
| Mar 31, 2025 | 159,000.00 |
| Dec 31, 2024 | 50.42 Mn |
| Dec 31, 2024 | 50.42 Mn |
| Sep 30, 2024 | -31.39 Mn |
| Sep 30, 2024 | -31.39 Mn |
| Jun 30, 2024 | 31.58 Mn |
| Jun 30, 2024 | 31.58 Mn |
| Mar 31, 2024 | 186,000.00 |
| Mar 31, 2024 | 186,000.00 |
| Dec 31, 2023 | 8.76 Mn |
| Dec 31, 2023 | 8.76 Mn |
| Sep 30, 2023 | 41.96 Mn |
| Sep 30, 2023 | 41.96 Mn |